Advertisement

Topics

Roche receives FDA Priority Review for drug with potted history

06:05 EDT 24 Aug 2017 | Pharmafile

Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that the agency has accepted its BLA. The application process will be watched with some interest after the drug has already caused quite a stir before even reaching the market.

read more

Original Article: Roche receives FDA Priority Review for drug with potted history

NEXT ARTICLE

More From BioPortfolio on "Roche receives FDA Priority Review for drug with potted history"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...